Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786797 · ClinicalTrials.gov registry record · NA
Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT02786797: Completed NA study, sponsored by University of South Florida.
NCT02786797 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786797, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate MBSR(BC), an intensive meditation-based stress reduction intervention, in order to determine its efficacy in improving cognitive functioning among breast cancer survivors. The study will employ a three group randomized design that will (1) evaluate the extent to which MBSR(BC) compared to the Breast Cancer-Education Support (BCES) program or Usual Care (UC) improves cognitive functioning among breast cancer survivors off treatment; (2) determine if improvements in cognitive functioning achieved from MBSR(BC) are mediated through increased mindfulness and decreased rumination and stress; (3) evaluate genetic variants as moderators of MBSR(BC) on improvements in CI; and (4) determine the impact of MBSR(BC) on healthcare utilization and costs, in addition it will be delivered to a sub-group in Spanish. If shown to be efficacious, the possibility exists of utilizing this intervention in other types of cancers as well as non-cancer health-related disorders in order to minimize the morbidity experienced by these populations.
Primary Outcome
Executive functioning is assessing the ability to develop, carry out, and make necessary changes to plans that have a goal. This will be measured using the Stroop Neuropsychological Screening Test (SNST).
Interventions
- BEHAVIORAL MBSR(BC) 6 Week Program
- BEHAVIORAL BCES 6 Week Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2016-03-07 |
| Est. Completion | 2020-07 |
| Phase | NA |
What the finished NCT02786797 record still lists
NCT02786797 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which MBSR(BC) 6 Week Program is the first listed.
NCT02786797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786797 about?
NCT02786797 is a clinical study titled "Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors". The purpose of this study is to evaluate MBSR(BC), an intensive meditation-based stress reduction intervention, in order to determine its efficacy in improving cognitive functioning among breast cancer survivors. The study will employ a three group randomized design that will (1) evaluate the extent...
What is the current status of trial NCT02786797?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2016-03-07. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02786797?
The interventions under investigation include: MBSR(BC) 6 Week Program (BEHAVIORAL), BCES 6 Week Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02786797?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02786797's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI